|
|
Volumn 35, Issue 5-6, 1999, Pages 511-514
|
|
The utility of prostate-specific antigen as a surrogate marker for identification of high-risk cohorts and assessing response in chemoprevention trials
|
|
Author keywords
Chemoprevention; PSA as surrogate marker
|
|
Indexed keywords
ANDROGEN;
ANTINEOPLASTIC AGENT;
PROSTATE SPECIFIC ANTIGEN;
TUMOR MARKER;
CANCER PREVENTION;
CANCER RISK;
CONFERENCE PAPER;
DISEASE MARKER;
HIGH RISK POPULATION;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COHORT STUDIES;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
POLYMERASE CHAIN REACTION;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATIC NEOPLASMS;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0032893380
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019890 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (14)
|
